Intriguing clinical trial coverage of a combined amylin and GLP-1 diabetes therapy, summarizing study design, safety signals, and potential clinical implications for patients.
Key Takeaways
- Hormone produced in the pancreas along with insulin
- Amylin helps balance blood glucose levels and makes people feel full after eating
- Amylin agonists—synthetic versions that mimic the effects of the natural hormone—are a newer class of drugs